The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Kaiser Health Policy News Index is designed to help journalists and policymakers better understand which health policy-related news stories Americans are following, and what the public knows about health policy issues covered in the news. This analysis examines the top health policy news stories in 2016.
As the problem of prescription painkiller abuse has captured greater attention from policymakers and the media, the November Kaiser Health Tracking Poll explores the public’s connection to and knowledge of the issue, as well as their views of how to address it. A surprising 56 percent of the public say they have some personal connection to the issue – either because they say they know someone who has taken a prescription painkiller that wasn’t prescribed to them, know someone who has been addicted, or know someone who has died from a prescription painkiller overdose. While views of the health care law have been narrowly divided for much of the year, this month more say they have an unfavorable view of the law than a favorable one. The poll also includes views of the uninsured during the third open enrollment period under the health care law.
This infographic provides information and statistics about the opioid epidemic and Medicaid’s role in covering addiction treatment services.
As the largest payer of substance use disorder services in the United States, Medicaid plays a central role in state efforts to address the opioid epidemic. In addition to increasing access to addiction treatment services through the expansion of Medicaid under the Affordable Care Act (ACA), states are expanding Medicaid addiction treatment services, increasing provider reimbursements, restricting opioid prescribing, and implementing delivery system reforms to improve the quality of treatment services. While many states have been tracking progress and challenges in these efforts, uniqueness of state systems can make it difficult to compare or benchmark across states. This brief draws on analyses provided by the Medicaid Outcomes Distributed Research Network (MODRN), a collaborative effort to analyze data across multiple states to facilitate learning among Medicaid agencies. It profiles the opioid epidemic among the Medicaid population in six states participating in MODRN that also have been hard hit by the opioid epidemic: Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia. The brief also draws on interviews with officials from the state Medicaid and other health agencies.
This report provides data to understand current patterns of Medicaid enrollees’ use of inpatient and outpatient substance use disorder and mental health treatment services; explains the options for states to access federal Medicaid funds for enrollees receiving IMD services; analyzes current Section 1115 waiver activity; and draws on interviews with policymakers using IMD waivers in Vermont, Virginia, and San Diego County to examine successes and challenges
This data note describes uninsured nonelderly adults with opioid use disorder, including their demographic characteristics, health status, and access to treatment.
Amid the coronavirus pandemic, half of Americans report that their mental health has been negatively impacted due to related stress and worry.
This issue brief provides an overview of Medicaid’s role in financing behavioral health services. It includes information on eligibility, benefits, service delivery, access to care, and spending. It also discusses the potential impact of Medicaid restructuring as proposed in the Better Care Reconciliation Act.
Former President Trump has routinely blamed undocumented immigrants for a rise in drug trafficking and overdose deaths…But most fentanyl is being trafficked by American citizens. …
This brief analyzes the latest CDC data on adolescent overdose deaths, finding that from 2022 to 2023, there was a small reduction in overdose fatalities among adolescents (from 721 to 708 deaths). Additionally, the synthetic opioid, fentanyl, has largely driven the increase in adolescent drug fatalities since the pandemic began, accounting for 76% of these fatalities in 2023. This analysis also explores federal and state policy responses to the drug crisis, such as requirements to stock naloxone in schools, accountability for social media companies, and national prevention education efforts.
© 2026 KFF